ATN-224 enhances antitumor efficacy of oncolytic herpes virus against both local and metastatic head and neck squamous cell carcinoma
Ji Young Yoo(The University of Texas MD Anderson Cancer Center), Matthew Old, Balveen Kaur(Augusta University), Andrew P. Mazar(Northwestern University), Pawan Kumar(The Ohio State University), Jianying Zhang(Shanxi Agricultural University), Quintin Pan(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Jun-Ge Yu(The Ohio State University Wexner Medical Center), Azeem Kaka(Emory University), Theodoros N. Teknos(University Hospitals Seidman Cancer Center), Bhavna Kumar(Dehradun Institute of Technology University)
Cited by 12
Related Papers
Objective assessment of swallowing dysfunction and aspiration after radiation concurrent with chemotherapy for head-and-neck cancer
|International Journal of Radiation Oncology*Biology*Physics|2002|508
Genome-wide analysis of HPV integration in human cancers reveals recurrent, focal genomic instability
|Genome Research|2013|485
Pan-cancer single-cell RNA-seq identifies recurring programs of cellular heterogeneity
|Nature Genetics|2020|465
Clinical Predictors of Quality of Life in Patients With Head and Neck Cancer
|Archives of Otolaryngology - Head and Neck Surgery|2004|454
Cyclophosphamide enhances glioma virotherapy by inhibiting innate immune responses
|Proceedings of the National Academy of Sciences|2006|360